Keep an eye on this tech stock - after years of loses, rights issues, etc things look to be moving in the right direction. Tipped by Redmayne last year it could be a winner.

Protherics PLC
20 January 2006



PROTHERICS PLC


NOTIFICATION OF MAJOR INTERESTS IN SHARES


20 January 2005: Protherics PLC (the 'Company'), the biopharmaceutical company
focused on critical care and oncology, received notification on 19 January 2006
from AXA Investment Managers UK Limited on behalf of AXA S.A. and its Group
Company ('AXA S.A.') that, on 18 January 2006, AXA S.A. held an interest in
32,099,803 ordinary 2p shares (the 'Shares') in the share capital of the Company
(12.43%).



The Shares are represented by a beneficial interest in 10,000 ordinary shares
(0.004%) and a non-beneficial interest in 32,089,803 ordinary shares (12.422%).



This notification follows an increase in the Company's issued share capital to
258,328,129 ordinary shares.

Lots of splendid news hlyeo98. I especially like the "The agreement has
further potential milestone payments worth up to 171 million and Protherics
will also receive a 20 percent net royalty on the net global sales of CytoFabTM", piece!

There is also a positive article on PTI in the Shares Magazine this week

Indeed - good day today as well. Break 1 tomorrow me thinks.

q1,

Well at present your pediction is wrong. This is not a dig, as I also thought it would break the 1 line. All the indications were looking like a plus 1 today but I suppose there is most of the trading day left. It just shows how volatile share dealing can be. Still I now expect a few small adjustments till we get some news.

There was huge selling yesterday of 2 blocks of more than 1,000,000 each.

greekman - no dig assumed but it did break 1 today, it just didn't stay there...

L2 looking good. 2 on the bid, against 8 on the ask. If the next 3 Set's on the bid go, I would expect it to end up a bit better that the present price of 2.5p down.

I give in trying to read this share.

Hey, what's going on? PTI dropped 5p to 88p today.

When are they going to announce RNS? It is dropping again today to 85.5p now

Back up we go...

A snippet from Sharecast.


AstraZeneca's ditching of Exanta demonstrates the markets faith in the ability of AZ to tackle its meagre pipeline of new products by buying in the necessary new science. With $6 billion of free cash, it should have the financial clout to seal the best deals going says the Times.

My view..... You never know, with their cash, acquisitions may be a way to go. Or they may look toward such companies as Protherics for further licensing agreements. Every little helps.

Nice little article about Crofab.

Fougera Marks Sixth Snakebite Season with CroFab Crotalidae Polyvalent Immune Fab (Ovine)


http://www.primezone.com/newsroom/news.html?d=95910

keep your nerve chaps........lots of upside to come....